SEC 13F Intelligence

Managers / Q4 2019 · view latest →

CVI Holdings, LLC

CIK 0001728194 · ONE COMMERCE CENTER, 1201 N. ORANGE STREET, SUITE 715, WILMINGTON, DE, 19801 · 6106172600

Reported Value
$71M
Q4 2019
Positions
36
Filings on Record
25
2019–present window
Filed
Feb 14, 2020
original filing

Summary

Cvi Holdings, LLC reported $71M in U.S.-listed holdings across 36 positions for Q4 2019.

The portfolio is heavily concentrated: ABEO1EUR alone accounts for 24.1% of reported value.

Compared with Q3 2019, the fund opened 15 new positions and exited 60.

Portfolio Metrics

Turnover
+53.0%
vs prior filed quarter
Top-10 Concentration
+86.8%
share of reported value
Largest Position
+24.1%
Abeona Therapeutics
New / Exited
15 / 60
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $45MQ4 ’18Q1 ’19: $106MQ2 ’19: $172MQ3 ’19: $131MQ3 ’19Q4 ’19: $71MQ1 ’20: $28MQ2 ’20: $270MQ2 ’20Q3 ’20: $246MQ4 ’20: $536MQ1 ’21: $1.4BQ1 ’21Q2 ’21: $1.5BQ3 ’21: $1.6BQ4 ’21: $1.5BQ4 ’21Q1 ’22: $1.5BQ2 ’22: $1.4BQ3 ’22: $1.3BQ3 ’22Q4 ’22: $784MQ1 ’23: $266MQ2 ’23: $95MQ2 ’23Q3 ’23: $51MQ4 ’23: $48MQ1 ’24: $106MQ1 ’24Q2 ’24: $116Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 72.4%US DOMESTIC: 17.2%Other: 10.4%
  • Common Stock · 72.4% · $51M
  • US DOMESTIC · 17.2% · $12M
  • Other · 10.4% · $7M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ABEO1EURABEONA THERAPEUTICS INCNEW+5.23M5.23M+$17M$17M
AMRSEURAMYRIS INCNEW+2.08M2.08M+$6M$6M
REPLREPLIMUNE GROUP INCNEW+410.5K410.5K+$6M$6M
NABRIVA THERAPEUTICS PLCNEW+3.47M3.47M+$5M$5M
HEXO CORPNEW+2.33M2.33M+$4M$4M
MCF1EURCONTANGO OIL & GAS COMPANYNEW+700.0K700.0K+$3M$3M
FLNACASSAVA SCIENCES INCNEW+452.2K452.2K+$2M$2M
ATRECA INCNEW+83.0K83.0K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2019

36 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ABEO1EURABEONA THERAPEUTICS INChistory →COM24.08%$17M5.23M
2TIMKENSTEEL CORPNOTE 6.000% 6/015.11%$11M10.46M
3AMRSEURAMYRIS INChistory →COM NEW9.05%$6M2.08M
4REPLREPLIMUNE GROUP INChistory →COM8.30%$6M410.5K
5MNKDMANNKIND CORPhistory →COM NEW6.73%$5M3.71M
6NABRIVA THERAPEUTICS PLCSHS6.45%$5M3.47M
7HEXO CORPCOM5.22%$4M2.33M
8XCUREXICURE INChistory →COM4.89%$3M1.21M
9MCF1EURCONTANGO OIL & GAS COMPANYhistory →COM NEW3.62%$3M700.0K
10FLNACASSAVA SCIENCES INChistory →COM3.31%$2M452.2K
11SENSEONICS HLDGS INCNOTE 5.250% 2/02.10%$1M1.50M
12NAKNORTHERN DYNASTY MINERALS LThistory →COM NEW1.98%$1M3.28M
13ATRECA INCCL A COM1.81%$1M83.0K
14YB4PSAVARA INChistory →COM1.29%$917,000204.7K
15VASCULAR BIOGENICS LTDCOM1.13%$801,000667.8K
16OGXIEURACHIEVE LIFE SCIENCE INCCOM NEW0.87%$620,0001.17M
17SCYNEXIS INCCOM0.83%$586,000643.7K
18BCRXBIOCRYST PHARMACEUTICALSCOM0.72%$514,000149.0K
19RGLSUSDREGULUS THERAPEUTICS INCCOM NEW0.48%$344,000386.0K
20AMPIO PHARMACEUTICALS INCCOM0.46%$324,000556.5K
21GOLDEN MINERALS COCOM0.45%$317,0001.02M
22BIONDVAX PHARMACEUTICALS LTD*W EXP 05/15/2020.27%$189,00072.8K
23CHINA CERAMICS CO LTDSHS0.19%$136,000199.8K
24FARMMI INCSHS0.16%$117,000156.1K
25VERB TECHNOLOGY CO INC*W EXP 03/14/2020.15%$108,000240.0K
26LIPOCINE INC NEWCOM0.15%$105,000272.5K
27FLEXSHOPPER INC*W EXP 09/28/2020.08%$58,00038.4K
28SIGMA LABS INC*W EXP 02/15/2020.03%$23,00048.1K
29ARTELO BIOSCIENCES INC*W EXP 06/25/2020.03%$19,00065.0K
30CHECK CAP LTD*W EXP 05/03/2020.02%$16,000136.4K
31MEDIGUS LTD*W EXP 07/23/2020.01%$6,00063.3K
32AMERI HLDGS INC*W EXP 11/08/2020.01%$4,00098.7K
33BENITEC BIOPHARMA LTD*W EXP 08/14/2020.01%$4,00050.0K
34PLUS THERAPEUTICS INC*W EXP 05/28/2020.00%$1,000259.2K
35CREATIVE REALITIES INC*W EXP 11/09/2020.00%$1,00015.0K
36ENERGY FUELS INC*W EXP 09/20/2020.00%$0277.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2024$116M144Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$106M157May 7, 202413F-HRchanges · EDGAR ↗
Q4 2023$48M187Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$51M229Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$95M277Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$266M413May 16, 202313F-HRchanges · EDGAR ↗
Q4 2022$784M615Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.3B882Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B930Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.5B928May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.5B948Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.6B899Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.5B790Aug 11, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.4B615May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$536M182Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$246M83Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$270M70Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$28M37May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$71M36Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019REVEALED$131M107Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019REVEALED$172M118Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$106M58May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$45M42Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • HEIGHTS CAPITAL MANAGEMENT, INC028-13218
  • CVI Investments, Inc.028-17822

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.